Loading…
Combined Measurements of Cardiac Troponin T and N-Terminal Pro-Brain Natriuretic Peptide in Patients With Heart Failure
Background To examine the prognostic contribution of combined cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with heart failure (CHF) in the absence of acute coronary syndrome. Methods and Results Between July 2001 and March 2002, 71 consecutive patien...
Saved in:
Published in: | Circulation Journal 2004, Vol.68(12), pp.1160-1164 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c481t-38f79985f95ec75dcbd28706201d287fd1fe1cc345ec740e7971a9a510df00103 |
---|---|
cites | cdi_FETCH-LOGICAL-c481t-38f79985f95ec75dcbd28706201d287fd1fe1cc345ec740e7971a9a510df00103 |
container_end_page | 1164 |
container_issue | 12 |
container_start_page | 1160 |
container_title | Circulation Journal |
container_volume | 68 |
creator | Taniguchi, Ryoji Sato, Yukihito Yamada, Tasuku Ooba, Muneo Higuchi, Hirokazu Matsumori, Akira Kimura, Takeshi Kita, Toru |
description | Background To examine the prognostic contribution of combined cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with heart failure (CHF) in the absence of acute coronary syndrome. Methods and Results Between July 2001 and March 2002, 71 consecutive patients (mean age = 68.4±1.4 years, 37 men), hospitalised for heart failure, were studied during hospitalisation and follow up until December 2002. Serum cTnT and NT-proBNP were measured on admission. Actuarial rates of adverse cardiac events, including sudden or CHF death, or rehospitalisation for CHF during follow up were compared with patients grouped according to initial serum cTnT and/or NT-proBNP concentrations. The adverse cardiac event-free rate among the 20 patients with cTnT ≥0.01 ng/ml was significantly lower than the 51 patients with cTnT |
doi_str_mv | 10.1253/circj.68.1160 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67111403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67111403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-38f79985f95ec75dcbd28706201d287fd1fe1cc345ec740e7971a9a510df00103</originalsourceid><addsrcrecordid>eNpNkLtuGzEQRYnAhq04LtMarNytPLPvLRM5jgzIjgoFKYkROWtR2IdCUjDy99mVhCjNcMB75hRXiM8IU4yz5EFbp7fTvJwi5vBBTDBJiygtY7g47HlUlWlyLT56vwWIK8iqK3GNWZanBcBEvM_6dm07NvKFye8dt9wFL_tazsgZS1quXL_rO9vJlaTOyNdoxa61HTVy6froq6MheqXg7HAcrJZL3gVrWA7fSwr2oPtlw0bOmVyQT2SbgfwkLmtqPN-e3hvx8-nbajaPFj--P8--LCKdlhiipKyLqiqzuspYF5nRaxOXBeQx4LjUBmtGrZN0jFPgoiqQKsoQTA2AkNyI-6N35_rfe_ZBtdZrbhrquN97lReImEIygNER1K733nGtds625P4oBDU2rQ5Nq7xUY9MDf3cS79ctmzN9qnYAHo_A1gd643_AUILVDf-ni09z9J7jDTnFXfIXVfGS7Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67111403</pqid></control><display><type>article</type><title>Combined Measurements of Cardiac Troponin T and N-Terminal Pro-Brain Natriuretic Peptide in Patients With Heart Failure</title><source>Freely Accessible Journals</source><creator>Taniguchi, Ryoji ; Sato, Yukihito ; Yamada, Tasuku ; Ooba, Muneo ; Higuchi, Hirokazu ; Matsumori, Akira ; Kimura, Takeshi ; Kita, Toru</creator><creatorcontrib>Taniguchi, Ryoji ; Sato, Yukihito ; Yamada, Tasuku ; Ooba, Muneo ; Higuchi, Hirokazu ; Matsumori, Akira ; Kimura, Takeshi ; Kita, Toru</creatorcontrib><description>Background To examine the prognostic contribution of combined cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with heart failure (CHF) in the absence of acute coronary syndrome. Methods and Results Between July 2001 and March 2002, 71 consecutive patients (mean age = 68.4±1.4 years, 37 men), hospitalised for heart failure, were studied during hospitalisation and follow up until December 2002. Serum cTnT and NT-proBNP were measured on admission. Actuarial rates of adverse cardiac events, including sudden or CHF death, or rehospitalisation for CHF during follow up were compared with patients grouped according to initial serum cTnT and/or NT-proBNP concentrations. The adverse cardiac event-free rate among the 20 patients with cTnT ≥0.01 ng/ml was significantly lower than the 51 patients with cTnT <0.01 ng/ml (P<0.05). Similarly, the adverse cardiac event-free rate among the 36 patients with NT-proBNP ≥1,357 pg/ml (median) was significantly lower than the 35 patients with NT-proBNP <1,357 pg/ml (P<0.01). The 16 patients with high concentrations of both cTnT and NT-proBNP had a lower adverse cardiac event-free rate than the 31 patients with low cTnT and low NT-proBNP upon commencement of the study (P<0.005). Conclusion Measurements of serum cTnT and NT-proBNP were reliable prognostic markers of adverse cardiac event in patients with CHF. (Circ J 2004; 68: 1160 - 1164)</description><identifier>ISSN: 1346-9843</identifier><identifier>EISSN: 1347-4820</identifier><identifier>DOI: 10.1253/circj.68.1160</identifier><identifier>PMID: 15564700</identifier><language>eng</language><publisher>Japan: The Japanese Circulation Society</publisher><subject>Aged ; Cardiac Output, Low - blood ; Cardiac Output, Low - complications ; Cardiac Output, Low - metabolism ; Cardiac Output, Low - mortality ; Chronic Disease ; Death, Sudden, Cardiac ; Female ; Follow-Up Studies ; Heart Diseases - etiology ; Heart Diseases - mortality ; Heart failure ; Humans ; Male ; Middle Aged ; Myocardium - metabolism ; Natriuretic Peptide, Brain ; Nerve Tissue Proteins - blood ; Nerve Tissue Proteins - metabolism ; Patient Readmission - statistics & numerical data ; Peptide Fragments - blood ; Peptide Fragments - metabolism ; Pro-brain natriuretic peptide ; Prognosis ; Troponin ; Troponin T - blood ; Troponin T - metabolism</subject><ispartof>Circulation Journal, 2004, Vol.68(12), pp.1160-1164</ispartof><rights>2004 THE JAPANESE CIRCULATION SOCIETY</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-38f79985f95ec75dcbd28706201d287fd1fe1cc345ec740e7971a9a510df00103</citedby><cites>FETCH-LOGICAL-c481t-38f79985f95ec75dcbd28706201d287fd1fe1cc345ec740e7971a9a510df00103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15564700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taniguchi, Ryoji</creatorcontrib><creatorcontrib>Sato, Yukihito</creatorcontrib><creatorcontrib>Yamada, Tasuku</creatorcontrib><creatorcontrib>Ooba, Muneo</creatorcontrib><creatorcontrib>Higuchi, Hirokazu</creatorcontrib><creatorcontrib>Matsumori, Akira</creatorcontrib><creatorcontrib>Kimura, Takeshi</creatorcontrib><creatorcontrib>Kita, Toru</creatorcontrib><title>Combined Measurements of Cardiac Troponin T and N-Terminal Pro-Brain Natriuretic Peptide in Patients With Heart Failure</title><title>Circulation Journal</title><addtitle>Circ J</addtitle><description>Background To examine the prognostic contribution of combined cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with heart failure (CHF) in the absence of acute coronary syndrome. Methods and Results Between July 2001 and March 2002, 71 consecutive patients (mean age = 68.4±1.4 years, 37 men), hospitalised for heart failure, were studied during hospitalisation and follow up until December 2002. Serum cTnT and NT-proBNP were measured on admission. Actuarial rates of adverse cardiac events, including sudden or CHF death, or rehospitalisation for CHF during follow up were compared with patients grouped according to initial serum cTnT and/or NT-proBNP concentrations. The adverse cardiac event-free rate among the 20 patients with cTnT ≥0.01 ng/ml was significantly lower than the 51 patients with cTnT <0.01 ng/ml (P<0.05). Similarly, the adverse cardiac event-free rate among the 36 patients with NT-proBNP ≥1,357 pg/ml (median) was significantly lower than the 35 patients with NT-proBNP <1,357 pg/ml (P<0.01). The 16 patients with high concentrations of both cTnT and NT-proBNP had a lower adverse cardiac event-free rate than the 31 patients with low cTnT and low NT-proBNP upon commencement of the study (P<0.005). Conclusion Measurements of serum cTnT and NT-proBNP were reliable prognostic markers of adverse cardiac event in patients with CHF. (Circ J 2004; 68: 1160 - 1164)</description><subject>Aged</subject><subject>Cardiac Output, Low - blood</subject><subject>Cardiac Output, Low - complications</subject><subject>Cardiac Output, Low - metabolism</subject><subject>Cardiac Output, Low - mortality</subject><subject>Chronic Disease</subject><subject>Death, Sudden, Cardiac</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart Diseases - etiology</subject><subject>Heart Diseases - mortality</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myocardium - metabolism</subject><subject>Natriuretic Peptide, Brain</subject><subject>Nerve Tissue Proteins - blood</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Patient Readmission - statistics & numerical data</subject><subject>Peptide Fragments - blood</subject><subject>Peptide Fragments - metabolism</subject><subject>Pro-brain natriuretic peptide</subject><subject>Prognosis</subject><subject>Troponin</subject><subject>Troponin T - blood</subject><subject>Troponin T - metabolism</subject><issn>1346-9843</issn><issn>1347-4820</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><recordid>eNpNkLtuGzEQRYnAhq04LtMarNytPLPvLRM5jgzIjgoFKYkROWtR2IdCUjDy99mVhCjNcMB75hRXiM8IU4yz5EFbp7fTvJwi5vBBTDBJiygtY7g47HlUlWlyLT56vwWIK8iqK3GNWZanBcBEvM_6dm07NvKFye8dt9wFL_tazsgZS1quXL_rO9vJlaTOyNdoxa61HTVy6froq6MheqXg7HAcrJZL3gVrWA7fSwr2oPtlw0bOmVyQT2SbgfwkLmtqPN-e3hvx8-nbajaPFj--P8--LCKdlhiipKyLqiqzuspYF5nRaxOXBeQx4LjUBmtGrZN0jFPgoiqQKsoQTA2AkNyI-6N35_rfe_ZBtdZrbhrquN97lReImEIygNER1K733nGtds625P4oBDU2rQ5Nq7xUY9MDf3cS79ctmzN9qnYAHo_A1gd643_AUILVDf-ni09z9J7jDTnFXfIXVfGS7Q</recordid><startdate>20041201</startdate><enddate>20041201</enddate><creator>Taniguchi, Ryoji</creator><creator>Sato, Yukihito</creator><creator>Yamada, Tasuku</creator><creator>Ooba, Muneo</creator><creator>Higuchi, Hirokazu</creator><creator>Matsumori, Akira</creator><creator>Kimura, Takeshi</creator><creator>Kita, Toru</creator><general>The Japanese Circulation Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041201</creationdate><title>Combined Measurements of Cardiac Troponin T and N-Terminal Pro-Brain Natriuretic Peptide in Patients With Heart Failure</title><author>Taniguchi, Ryoji ; Sato, Yukihito ; Yamada, Tasuku ; Ooba, Muneo ; Higuchi, Hirokazu ; Matsumori, Akira ; Kimura, Takeshi ; Kita, Toru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-38f79985f95ec75dcbd28706201d287fd1fe1cc345ec740e7971a9a510df00103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aged</topic><topic>Cardiac Output, Low - blood</topic><topic>Cardiac Output, Low - complications</topic><topic>Cardiac Output, Low - metabolism</topic><topic>Cardiac Output, Low - mortality</topic><topic>Chronic Disease</topic><topic>Death, Sudden, Cardiac</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart Diseases - etiology</topic><topic>Heart Diseases - mortality</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myocardium - metabolism</topic><topic>Natriuretic Peptide, Brain</topic><topic>Nerve Tissue Proteins - blood</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Patient Readmission - statistics & numerical data</topic><topic>Peptide Fragments - blood</topic><topic>Peptide Fragments - metabolism</topic><topic>Pro-brain natriuretic peptide</topic><topic>Prognosis</topic><topic>Troponin</topic><topic>Troponin T - blood</topic><topic>Troponin T - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Taniguchi, Ryoji</creatorcontrib><creatorcontrib>Sato, Yukihito</creatorcontrib><creatorcontrib>Yamada, Tasuku</creatorcontrib><creatorcontrib>Ooba, Muneo</creatorcontrib><creatorcontrib>Higuchi, Hirokazu</creatorcontrib><creatorcontrib>Matsumori, Akira</creatorcontrib><creatorcontrib>Kimura, Takeshi</creatorcontrib><creatorcontrib>Kita, Toru</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation Journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taniguchi, Ryoji</au><au>Sato, Yukihito</au><au>Yamada, Tasuku</au><au>Ooba, Muneo</au><au>Higuchi, Hirokazu</au><au>Matsumori, Akira</au><au>Kimura, Takeshi</au><au>Kita, Toru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Combined Measurements of Cardiac Troponin T and N-Terminal Pro-Brain Natriuretic Peptide in Patients With Heart Failure</atitle><jtitle>Circulation Journal</jtitle><addtitle>Circ J</addtitle><date>2004-12-01</date><risdate>2004</risdate><volume>68</volume><issue>12</issue><spage>1160</spage><epage>1164</epage><pages>1160-1164</pages><issn>1346-9843</issn><eissn>1347-4820</eissn><abstract>Background To examine the prognostic contribution of combined cardiac troponin T (cTnT) and N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients with heart failure (CHF) in the absence of acute coronary syndrome. Methods and Results Between July 2001 and March 2002, 71 consecutive patients (mean age = 68.4±1.4 years, 37 men), hospitalised for heart failure, were studied during hospitalisation and follow up until December 2002. Serum cTnT and NT-proBNP were measured on admission. Actuarial rates of adverse cardiac events, including sudden or CHF death, or rehospitalisation for CHF during follow up were compared with patients grouped according to initial serum cTnT and/or NT-proBNP concentrations. The adverse cardiac event-free rate among the 20 patients with cTnT ≥0.01 ng/ml was significantly lower than the 51 patients with cTnT <0.01 ng/ml (P<0.05). Similarly, the adverse cardiac event-free rate among the 36 patients with NT-proBNP ≥1,357 pg/ml (median) was significantly lower than the 35 patients with NT-proBNP <1,357 pg/ml (P<0.01). The 16 patients with high concentrations of both cTnT and NT-proBNP had a lower adverse cardiac event-free rate than the 31 patients with low cTnT and low NT-proBNP upon commencement of the study (P<0.005). Conclusion Measurements of serum cTnT and NT-proBNP were reliable prognostic markers of adverse cardiac event in patients with CHF. (Circ J 2004; 68: 1160 - 1164)</abstract><cop>Japan</cop><pub>The Japanese Circulation Society</pub><pmid>15564700</pmid><doi>10.1253/circj.68.1160</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1346-9843 |
ispartof | Circulation Journal, 2004, Vol.68(12), pp.1160-1164 |
issn | 1346-9843 1347-4820 |
language | eng |
recordid | cdi_proquest_miscellaneous_67111403 |
source | Freely Accessible Journals |
subjects | Aged Cardiac Output, Low - blood Cardiac Output, Low - complications Cardiac Output, Low - metabolism Cardiac Output, Low - mortality Chronic Disease Death, Sudden, Cardiac Female Follow-Up Studies Heart Diseases - etiology Heart Diseases - mortality Heart failure Humans Male Middle Aged Myocardium - metabolism Natriuretic Peptide, Brain Nerve Tissue Proteins - blood Nerve Tissue Proteins - metabolism Patient Readmission - statistics & numerical data Peptide Fragments - blood Peptide Fragments - metabolism Pro-brain natriuretic peptide Prognosis Troponin Troponin T - blood Troponin T - metabolism |
title | Combined Measurements of Cardiac Troponin T and N-Terminal Pro-Brain Natriuretic Peptide in Patients With Heart Failure |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T19%3A12%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Combined%20Measurements%20of%20Cardiac%20Troponin%20T%20and%20N-Terminal%20Pro-Brain%20Natriuretic%20Peptide%20in%20Patients%20With%20Heart%20Failure&rft.jtitle=Circulation%20Journal&rft.au=Taniguchi,%20Ryoji&rft.date=2004-12-01&rft.volume=68&rft.issue=12&rft.spage=1160&rft.epage=1164&rft.pages=1160-1164&rft.issn=1346-9843&rft.eissn=1347-4820&rft_id=info:doi/10.1253/circj.68.1160&rft_dat=%3Cproquest_cross%3E67111403%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c481t-38f79985f95ec75dcbd28706201d287fd1fe1cc345ec740e7971a9a510df00103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=67111403&rft_id=info:pmid/15564700&rfr_iscdi=true |